Cahill Michael A, Jazayeri Jalal A, Kovacevic Zaklina, Richardson Des R
School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia.
Molecular Pharmacology and Pathology Program, Department of Pathology, Bosch Institute, University of Sydney, Sydney, NSW, Australia.
Oncotarget. 2016 Aug 9;7(32):50822-50827. doi: 10.18632/oncotarget.10691.
Progesterone receptor membrane component 1 (PGRMC1) is a multifunctional protein implicated in multiple pathologies, including cancer and Alzheimer's disease. The recently published structure of PGRMC1 revealed heme-mediated dimerization that directed the PGRMC1-dependent cytochrome P450-mediated detoxification of doxorubicin. We describe here how the PGRMC1 structure also enables important new insights into the possible regulation of PGRMC1 function by phosphorylation. Predicted regulatory interaction sites for SH2- and SH3-domain proteins are in non-structured regions that could be available to cytoplasmic enzymes. Further to the published interpretation, we suggest that phosphorylation of PGRMC1 at position Y113 may promote the attested membrane trafficking function of PGRMC1. To stimulate further experimentation, we also discuss that heme-mediated dimerization of PGRMC1 and membrane trafficking may be mutually exclusive functions. These roles could potentially be reciprocally regulated by phosphorylation/dephosphorylation at Y113. It follows that the phosphorylation status of PGRMC1 should be further explored in order to better understand many of its proposed biological functions.
孕激素受体膜成分1(PGRMC1)是一种多功能蛋白,涉及多种病症,包括癌症和阿尔茨海默病。最近发表的PGRMC1结构揭示了血红素介导的二聚化,该二聚化指导了PGRMC1依赖的细胞色素P450介导的阿霉素解毒作用。我们在此描述PGRMC1结构如何也能为通过磷酸化对PGRMC1功能进行可能的调控提供重要的新见解。预测的SH2和SH3结构域蛋白的调控相互作用位点位于非结构化区域,细胞质酶可能可以接触到这些区域。除了已发表的解释,我们认为PGRMC1在Y113位点的磷酸化可能会促进已证实的PGRMC1的膜转运功能。为了刺激进一步的实验,我们还讨论了PGRMC1的血红素介导的二聚化和膜转运可能是相互排斥的功能。这些作用可能通过Y113位点的磷酸化/去磷酸化相互调节。因此,应该进一步探索PGRMC1的磷酸化状态,以便更好地理解其许多假定的生物学功能。